Skip to main content
    N

    National HealthCare Corporation (NHC)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • AMEX

    $205.79
    -1.40 (-0.68%)

    Market Cap: $3.26B

    Last updated: Nov 17, 2026 at 4:38 PM ET

    National HealthCare Corporation (NHC) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    National HealthCare (NHC) has a market cap of $3.26B and an enterprise value of $3.69B. Its trailing P/E of 28.6x is above its 10-year median of 20.0x.

    Total Valuation

    Enterprise value is 13.36% above the market cap, as debt exceeds cash.

    Market Cap$3.26B
    Enterprise Value$3.69B
    Latest price (Nov 17, 2026)$205.79

    Key Dates

    The next earnings report is expected on Feb 24, 2027, covering the quarter ending Dec 31, 2026. The next ex-dividend date is Dec 31, 2026.

    Next Earnings DateFeb 24, 2027 (expected)
    Last Earnings DateNov 6, 2026
    Next Ex-Dividend DateDec 31, 2026
    Next Payment DateJan 29, 2027
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.14% in the quarter ended Sep 30, 2026 and grew 0.73% a year over 2 years.

    Shares Outstanding15.64M
    Shares Change (YoY)+1.00%
    Shares Change (QoQ)+0.14%
    Share Count Growth (2Y CAGR)+0.73%

    Valuation Ratios

    Sales and book value multiples are 2.0x and 2.9x. Its year-end P/E ranged from 7.8x to 40.9x from 2016 to 2025.

    P/E Ratio28.6x
    P/S Ratio2.0x
    P/B Ratio2.9x
    P/TBV Ratio3.4x
    P/OCF Ratio14.7x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 16.6x EBITDA.

    EV / Earnings31.8x
    EV / Sales2.3x
    EV / EBITDA16.6x
    EV / EBIT21.6x

    Price Statistics

    The stock is up 62.02% over 52 weeks and trades 7.42% below its 50-day average.

    Beta (1Y)0.25
    52-Week Change+62.02%
    1-Month Change-13.98%
    3-Month Change-11.80%
    6-Month Change+5.65%
    5-Year Change+194.74%
    10-Year Change+218.61%
    Total Return (1Y)+64.08%
    Total Return (3Y CAGR)+41.82%
    Total Return (5Y CAGR)+26.62%
    Return vs SPY (1Y)+54.60%
    Max Drawdown (1Y)-18.49%
    Max Drawdown (3Y)-33.40%
    Sharpe Ratio (1Y)1.48
    Correlation with SPY (1Y)0.10
    50-Day Average$222.29
    200-Day Average$197.34
    52-Week Range$123.11 to $248.20
    RSI (14 Days)39.0
    Average Volume (20 Days)161.60K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.48x current liabilities, and total debt is 0.45x shareholder equity.

    Current Ratio1.48x
    Quick Ratio1.45x
    Debt / Equity0.45x
    Debt / EBITDA2.28x
    Interest Coverage21.11x

    Returns and Efficiency

    Return on invested capital is 8.08% over the last 12 months, against a 5-year average of 7.77%.

    Return on Equity (ROE)10.31%
    Return on Assets (ROA)5.61%
    Return on Invested Capital (ROIC)8.08%
    Return on Capital Employed (ROCE)9.57%
    ROE (5Y Average)9.35%
    ROA (5Y Average)6.24%
    ROIC (5Y Average)7.77%
    Asset Turnover0.87x
    Inventory Turnover111.92x
    Receivables Turnover11.85x
    Cash Conversion Cycle20 days

    Taxes

    Income tax took 22.98% of pretax income over the last 12 months.

    Income Tax (TTM)$34.62M
    Effective Tax Rate22.98%

    Scores

    NHC has an Altman Z-Score of 3.78, in the safe zone above 2.99, and a Piotroski F-Score of 8 of 9, in the strong band of 8 or 9.

    Altman Z-Score3.78
    Altman Z ZoneSafe
    Piotroski F-Score8 of 9
    Piotroski StrengthStrong

    Income Statement

    Revenue of $1.58B over the last 12 months is up 5.58% from the 12 months before.

    Revenue$1.58B
    Revenue Growth (YoY)+5.58%
    Gross Profit$622.18M
    Operating Income$154.94M
    Pretax Income$150.64M
    Net Income$116.02M
    EBITDA$219.87M
    EBIT$170.74M
    Reported EPS (TTM)$7.20

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 54.11% of the $2.07B in total assets.

    Cash and Equivalents$66.80M
    Total Debt$502.06M
    Net Debt$435.27M
    Net Debt Per Share$27.83
    Working Capital$135.91M
    Shareholder Equity$1.12B
    Book Value Per Share$71.93
    Tangible Book Value$934.08M
    Tangible Book Per Share$59.73
    Total Assets$2.07B
    Total Liabilities$936.98M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $610.39M of capital spending, operating cash flow left -$388.63M of free cash flow.

    Operating Cash Flow$221.76M
    Capital Expenditures$610.39M
    Free Cash Flow-$388.63M
    FCF Per Share-$24.81
    Depreciation and Amortization$49.13M
    Dividends Paid$40.66M
    Share Repurchases$29.84M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 9.78%, against a 5-year average of 5.61%.

    Gross Margin39.27%
    Operating Margin9.78%
    Pretax Margin9.51%
    Net Margin7.32%
    EBITDA Margin13.88%
    EBIT Margin10.78%
    FCF Margin-24.53%
    Gross Margin (5Y Average)37.94%
    Operating Margin (5Y Average)5.61%
    Net Margin (5Y Average)7.28%

    Growth

    Revenue grew 11.81% a year over 3 years, and EPS 75.69% a year.

    Revenue Growth (3Y CAGR)+11.81%
    Revenue Growth (5Y CAGR)+8.10%
    EPS Growth (3Y CAGR)+75.69%
    EPS Growth (5Y CAGR)+33.92%
    FCF Growth (5Y CAGR)-3.90%
    Operating Income Growth (3Y CAGR)+59.06%
    Book Value Per Share Growth (2Y CAGR)+7.89%
    Tangible Book Per Share Growth (2Y CAGR)+8.88%

    Revenue and profit by year

    Dividends and Yields

    NHC pays out 35.32% of earnings as dividends.

    Dividend Per Share (Annual)$2.68
    Dividend Yield1.30%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)+3.83%
    Dividend Growth (5Y CAGR)+3.99%
    Payout Ratio35.32%
    Earnings Yield3.50%
    FCF Yield-12.08%
    Buyback Yield0.13%
    Shareholder Yield1.40%

    Full dividend history

    Peer Position

    Against 10 similar companies, NHC has the 4th highest P/E and the 8th highest ROIC.

    P/E Ratio28.6x vs 20.5x median
    P/S Ratio2.0x vs 1.5x median
    ROIC8.08% vs 9.78% median
    Revenue Growth (Trailing 4 Quarters, YoY)+5.58% vs +7.11% median
    Dividend Yield1.30% vs 0.00% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About NHC

    What is NHC's market cap?

    National HealthCare has a market cap of $3.26B. Its enterprise value, which adds debt and subtracts cash, is $3.69B.

    What is NHC's P/E ratio?

    National HealthCare has a trailing P/E ratio of 28.6x.

    How many shares of NHC are outstanding?

    National HealthCare has 15.64M shares outstanding. The count is up 1.00% from a year earlier.

    Does NHC pay a dividend?

    Yes. National HealthCare pays $2.68 a share a year, a dividend yield of 1.30%.

    How much debt does NHC have?

    National HealthCare has $502.06M of total debt and $66.80M of cash and equivalents, a net debt position of $435.27M.